Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Acurx Pharmaceuticals, Inc. | 2,150 | reported | 20 Apr 2026 | tx 13+220,021−19,737 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Apr 2026 | GRANT_AWARD | Acurx Pharmaceuticals, Inc. | 2,150 | 0.00 USD | deriv |
| 06 Jan 2025 | PURCHASE | Acurx Pharmaceuticals, Inc. | 24,631 | 1.02 USD | |
| 06 Jan 2025 | PURCHASE | Acurx Pharmaceuticals, Inc. | 24,631 | 0.00 USD | derivfirst after silence |
| 17 Jun 2024 | GRANT_AWARD | Acurx Pharmaceuticals, Inc. | 12,000 | 0.00 USD | deriv |
| 19 Jan 2024 | EXERCISE | Acurx Pharmaceuticals, Inc. | 19,737 | 3.55 USD | |
| 19 Jan 2024 | EXERCISE | Acurx Pharmaceuticals, Inc. | 19,737 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | Acurx Pharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |
| 27 Jul 2022 | PURCHASE | Acurx Pharmaceuticals, Inc. | 19,737 | 3.80 USD | |
| 27 Jul 2022 | PURCHASE | Acurx Pharmaceuticals, Inc. | 19,737 | 0.00 USD | deriv |
| 27 Jul 2022 | PURCHASE | Acurx Pharmaceuticals, Inc. | 19,737 | 0.00 USD | deriv |
| 23 Nov 2021 | PURCHASE | Acurx Pharmaceuticals, Inc. | 5,161 | 4.84 USD | |
| 29 Jun 2021 | PURCHASE | Acurx Pharmaceuticals, Inc. | 12,500 | 6.00 USD | |
| 01 Jul 2021 | GRANT_AWARD | Acurx Pharmaceuticals, Inc. | 50,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 06 Jan 2025.